Skip to main content

Table 2 Comparison between the studied groups according to clinical data

From: Role of Fibroscan for early detection of hepatocellular carcinoma (HCC) in hepatitis C cirrhotic patients

Clinical data Group (I) HCC n = 25 Group (II) cirrhosis n = 25 P value
n % n %
Jaundice 13 52 3 12 0.03*
Clubbing 20 80 9 36 < 0.001*
Ecchymosis 19 76 10 40 0.02*
Hepatomegaly 2 8 6 24 0.5
Hard liver 10 40 0 0 0.004*
Splenomegaly 18 72 20 80 0.13
Abdominal pain 15 60 10 40 0.903
Easy fatigability 20 80 16 64 0.65
Loss of weight 22 88 20 80 0.865
  1. *Significant